Adapting paintrainer: a digital intervention for enhancing pain management in young adult cancer survivors
Active Grant Awarded
- Award ID
- R34CA300995
- Recipient
-
Northwestern University UEI KG76WYENL5K1
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $962,119
Award facts
- Assistance listing
- 93.279 Drug Use and Addiction Research Programs
- Completion date 7% complete
- Funding agency
- National Institute of Neurological Disorders and Stroke National Institutes of Health, Department of Health and Human Services
- Place of performance
- Chicago, IL 60611, USA
Award details come from USAspending.gov.
About this award
The Department of Health and Human Services National Institutes of Health National Institute of Neurological Disorders and Stroke awarded Northwestern University $962,119 on September 9, 2026, under Grant R34CA300995, Drug Use and Addiction Research Programs (Assistance Listing 93.279). The parent program's stated purpose is research on substance use, drug overdose, and related health outcomes.
The award funds adapting and piloting PAINTRAINER, a web-based, disease-agnostic digital intervention for chronic pain grounded in cognitive-behavioral therapy principles, for young adult cancer survivors aged 18 to 39 who have completed cancer treatment. The source states that PAINTRAINER was designed primarily for adults 65 and older, and that its content presentation must be tailored to young adults to encourage adoption. Aim 1 elicits qualitative feedback on the proposed adaptations from 20 young adult survivors and an expert panel of clinicians. The work proceeds in collaboration with an established community advisory board of young adult survivors who are social media influencers and create cancer-related online content for thousands of peers.
Place of performance is Chicago, Illinois 60611. The period of performance runs to an ultimate completion date of August 31, 2029. The source names no sub-recipients.
Description
- Abstract
- The overall goal of this project is to adapt and pilot an evidence-based digital intervention for chronic pain (PAINTRAINER) for young adult (YA) cancer survivors-a target population that differs culturally from the original sample in which the intervention was first designed. YAS are a growing cancer survivor population that has well- documented persistent post-treatment physical and psychosocial challenges, with chronic pain being common yet undertreated. Chronic pain reduces quality of life in YA survivors, including worsening physical and mental health and adding to the long-term financial burden of cancer. Digital strategies are promising for delivering accessible, non-pharmacological pain interventions to YAS at a large scale. MPI rini established the efficacy of PAINTRAINER-a web-based, disease-agnostic intervention for chronic pain that is grounded in cognitive- behavioral therapy principles and used by approximately 8,000 adults worldwide. However, PAINTRAINER was primarily designed for use in older adults (65+), who have different interactions with technology compared to YAS. YA survivors have informed US that although PAINTRAINER concepts are useful, how the content is presented must be tailored to YAS to encourage adoption. In the absence of careful adaptation, PAINTRAINER will not sufficiently engage or reach YAS, limiting its utility and impact. Therefore, we propose to adapt PAINTRAINER for YA cancer survivors who have completed cancer treatment and fall within the NCI-defined age range of 18-39. Aim 1 will elicit qualitative feedback about PAINTRAINER adaptations with YA survivors (N=20) and an expert panel of clinicians. In collaboration with an established community advisory board of YA survivors who are "social media influencers" (i.e., create and disseminate cancer-related online content to thousands of peers), we will leverage this feedback to create a prototype of the adapted intervention (called "YAS PAINTRAINER"), which will be further refined after usability testing. In aim 2, via a single-arm feasibility pilot, we will test the hypothesis that YAS PAINTRAINER will be feasible to implement and acceptable to YA cancer survivors. We will explore pre- and post-changes in pain severity and interference. Because YAS have shown low clinical trial enrollment and the majority stop attending annual survivorship care visits, novel recruitment strategies are needed to reach a large, representative sample of YAS who could benefit from the intervention. Aim 3 will establish a multi-method recruitment blueprint for reaching YAS with pain in our planned future YAS PAINTRAINER trial, with the goal of ensuring an efficient launch to recruitment for that trial. We will screen and select: 1) one more research site that serves a large YA survivor population and that is led by an investigator experienced in recruiting this population and 2) one or more national YA survivor advocacy groups that allow US to reach YAS who are not currently receiving survivorship care. We will deliver formal collaboration agreements with these new partners, source-specific sample size and demographic estimates, estimated budgets, and standard operating procedures, all designed to support the next grant and trial launch.
Quick answers
Who received award R34CA300995?
R34CA300995 was awarded to Northwestern University by National Cancer Institute (National Institutes of Health) on September 9, 2026.
How much is award R34CA300995 worth?
$962,119 has been obligated on R34CA300995.
Which agency awarded R34CA300995?
National Cancer Institute (National Institutes of Health) awarded R34CA300995, with funding from National Institute of Neurological Disorders and Stroke (National Institutes of Health).
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award